Sonoma Pharmaceuticals announces annual shareholder meeting - SNOA News | RalliesSonoma Pharmaceuticals announces annual shareholder meeting
S
SNOA• Annual shareholder meeting details
- Sonoma Pharmaceuticals will hold its 2026 annual stockholders meeting in Boulder, Colorado on Sept. 16, 2026.
- Shareholders will vote on the election of Jerry McLaughlin as a Class III director for a term ending at the 2028 annual meeting.
- An advisory vote is scheduled on executive compensation for the fiscal year ended March 31, 2026.
- Investors will also vote on ratifying Frazier & Deeter as independent auditor for the fiscal year ending March 31, 2027.
- A separate proposal seeks authorization to adjourn the meeting to solicit additional proxies if needed.
•
